Working memory deficits and levels of N-acetylaspartate in patients with schizophreniform disorder

American Journal of Psychiatry

Volumn 160, Issue 3, 2003, Pages 483-489

  Bertolino, Alessandro ^a   Sciota, Domenico ^b   Brudaglio, Flora ^b   Altamura, Mario ^b   Blasi, Giuseppe ^b   Bellomo, Antonello ^b   Antonucci, Nicola ^b   Callicott, Joseph H ^b   Goldberg, Terry E ^b   Scarabino, Tommaso ^b   Weinberger, Daniel R ^b   Nardini, Marcello ^b  

^a UNIVERSITY OF BARI   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; N ACETYLASPARTIC ACID; ASPARTIC ACID; CREATINE; DRUG DERIVATIVE; N-ACETYLASPARTATE;

ADULT; AMINO ACID BRAIN LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HIPPOCAMPUS; HUMAN; MALE; MEMORY DISORDER; MENTAL PATIENT; MENTAL TASK; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCHIZOPHRENIFORM DISORDER; TASK PERFORMANCE; WORKING MEMORY; CHEMISTRY; COMPARATIVE STUDY; METABOLISM; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PSYCHOSIS;

ADULT; ASPARTIC ACID; CREATINE; FEMALE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MEMORY DISORDERS; NEUROPSYCHOLOGICAL TESTS; PREFRONTAL CORTEX; PSYCHOTIC DISORDERS;

EID: 0037362598     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.160.3.483     Document Type: Article

References (36)

1. Goldman-Rakic PS: The physiological approach: functional architecture of working memory and disordered cognition in schizophrenia. Biol Psychiatry 1999; 46:650-661
2. Cohen JD, Perlstein WM, Braver TS, Nystrom LE, Noll DC, Jonides J, Smith EE: Temporal dynamics of brain activation during a working memory task. Nature 1997; 386:604-608
3. Callicott JH, Mattay VS, Bertolino A, Finn K, Coppola R, Frank JA, Goldberg TE, Weinberger DR: Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. Cereb Cortex 1999; 9:20-26
4. Manoach DS, Press DZ, Thangaraj V, Searl MM, Goff DC, Halpern E, Saper CB, Warach S: Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task, as measured by fMRI. Biol Psychiatry 1999; 45:1128-1137
5. Callicott JH, Bertolino A, Mattay VS, Langheim FJ, Duyn J, Coppola R, Goldberg TE, Weinberger DR: Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb Cortex 2000; 10:1078-1092
6. Bertolino A, Nawroz S, Mattay VS, Barnett AS, Duyn JH, Moonen CTW, Frank JA, Tedeschi G, Weinberger DR: Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am J Psychiatry 1996; 153:1554-1563
7. Deicken RF, Zhou L, Corwin F, Vinogradov S, Weiner MW: Decreased left frontal lobe N-acetylaspartate in schizophrenia. Am J Psychiatry 1997; 154:688-690
8. Brooks WM, Hodde-Vargas J, Vargas LA, Yeo RA, Ford CC, Hendren RL: Frontal lobe of children with schizophrenia spectrum disorders: a proton magnetic resonance spectroscopic study. Biol Psychiatry 1998; 43:263-269
9. Cecil KM, Lenkinski RE, Gur RE, Gur RC: Proton magnetic resonance spectroscopy in the frontal and temporal lobes of neuroleptic naive patients with schizophrenia. Neuropsychopharmacology 1998; 20:131-140
10. Bartha R, al-Semaan YM, Williamson PC, Drost DJ, Malla AK, Carr TJ, Densmore M, Canaran G, Neufeld RW: A short echo proton magnetic resonance spectroscopy study of the left mesial-temporal lobe in first-onset schizophrenic patients. Biol Psychiatry 1999; 45:1403-1411
11. Kegeles LS, Shungu DC, Anjilvel S, Chan S, Ellis SP, Xanthopoulos E, Malaspina D, Gorman JM, Mann JJ, Laruelle M, Kaufmann CA: Hippocampal pathology in schizophrenia: magnetic resonance imaging and spectroscopy studies. Psychiatry Res 2000; 98:163-175
12. Bertolino A, Callicott JH, Mattay VS, Weidenhammer KM, Rakow R, Egan MF, Weinberger DR: The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia. Biol Psychiatry 2001; 49:39-46
13. Braus DF, Ende G, Weber-Fahr W, Demirakca T, Henn FA: Favorable effect on neuronal viability in the anterior cingulate gyrus due to long-term treatment with atypical antipsychotics: an MRSI study. Pharmacopsychiatry 2001; 34:251-253
14. Ende G, Braus DF, Walter S, Weber-Fahr W, Soher B, Maudsley AA, Henn FA: Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia. Schizophr Res 2000; 41:389-395
15. Bustillo JR, Lauriello J, Rowland LM, Jung RE, Petropoulos H, Hart BL, Blanchard J, Keith SJ, Brooks WM: Effects of chronic haloperidol and clozapine treatments on frontal and caudate neurochemistry in schizophrenia. Psychiatry Res 2001; 107:135-149
16. 1H MRS studies. Neuroreport 1996; 7:1397-1400
17. De Stefano N, Matthews P, Antel JP, Preul M, Francis G, Arnold DL: Chemical pathology of acute demyelinating lesions and its correlations with disability. Ann Neurol 1995; 38:901-909
18. 1H magnetic resonance spectroscopic imaging. Ann Neurol 1996; 40:236-239
19. Jenkins BG, Klivenyi P, Kustermann E, Andreassen OA, Ferrante RJ, Rosen BR, Beal MF: Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease mice. J Neurochem 2000; 74:2108-2119
20. 18FDG-PET. Magn Reson Med 2000; 43:244-250
21. Vion-Dury J, Salvan AM, Confort-Gouny S, Dhiver C, Cozzone P: Reversal of brain metabolic alterations with zidovudine detected by proton localised magnetic resonance spectroscopy. Lancet 1995; 345:60-61
22. Bertolino A, Esposito G, Callicott JH, Mattay VS, Van Horn JD, Frank JA, Berman KF, Weinberger DR: Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia. Am J Psychiatry 2000; 157:26-33
23. Callicott JH, Bertolino A, Egan MF, Mattay VS, Langheim FJP, Weinberger DR: Selective relationship between prefrontal N-acetylaspartate measures and negative symptoms in schizophrenia. Am J Psychiatry 2000; 157:1646-1651
24. Iancu I, Dannon PN, Ziv R, Lepkifker E: A follow-up study of patients with DSM-IV schizophreniform disorder. Can J Psychiatry 2002; 47:56-60
25. First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV Axis I Disorders Research Version (SCID-I). New York, New York State Psychiatric Institute, Biometrics Research, 1996
26. Jung RE, Yeo RA, Chiulli SJ, Sibbitt WL Jr, Weers DC, Hart BL, Brooks WM: Biochemical markers of cognition: a proton MR spectroscopy study of normal human brain. Neuroreport 1999; 10:3327-3331
27. Jung RE, Brooks WM, Yeo RA, Chiulli SJ, Weers DC, Sibbitt WL Jr: Biochemical markers of intelligence: a proton MR spectroscopy study of normal human brain. Proc R Soc Lond B Biol Sci 1999; 266:1375-1379
28. Urenjak J, Williams SR, Gadian DG, Noble M: Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993; 13:981-989
29. Bhakoo KK, Pearce D: In vitro expression of N-acetyl aspartate by oligodendrocytes: implications for proton magnetic resonance spectroscopy in vivo. J Neurochem 2000; 74:254-262
30. Clark JB: N-Acetyl aspartate: a marker for neuronal loss or mitochondrial dysfunction. Dev Neurosci 1998; 20:271-276
31. 13C]glucose infusion. J Neurochem 2001; 77:347-350
32. Rubin Y, LaPlaca MC, Smith DH, Thibault LE, Lenkinski RE: The effect of N-acetylaspartate on the intracellular calcium concentration in NTera2-neurons. Neurosci Lett 1995; 198:209-212
33. Baslow MH, Kitada K, Suckow RF, Hungund BL, Serikawa T: The effects of lithium chloride and other substances on levels of brain N-acetyl-L-aspartic acid in Canavan disease-like rats. Neurochem Res 2002; 27:403-406
34. Friedman SD, Brooks WM, Jung RE, Hart BL, Yeo RA: Proton MR spectroscopic findings correspond to neuropsychological function in traumatic brain injury. AJNR Am J Neuroradiol 1998; 19:1879-1885
35. Lim KO, Adalsteinsson E, Spielman D, Sullivan EV, Rosenbloom MJ, Pfefferbaum A: Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia. Arch Gen Psychiatry 1998; 55:346-352
36. Pfefferbaum A, Adalsteinsson E, Spielman D, Sullivan EV, Lim KO: In vivo spectroscopic quantification of the N-acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: effects of normal aging. Magn Reson Med 1999; 41:276-284